Author: United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products
Publisher:
ISBN:
Category : Antilipemic agents
Languages : en
Pages : 20
Book Description
Guidelines for the Clinical Evaluation of Lipid-altering Agents in Adults and Children
Author: United States. Food and Drug Administration. Division of Metabolism and Endocrine Drug Products
Publisher:
ISBN:
Category : Antilipemic agents
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Antilipemic agents
Languages : en
Pages : 20
Book Description
Guidelines for the Clinical Evaluation of Radiopharmaceutical Drugs
Author: United States. Food and Drug Administration. Bureau of Drugs
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 24
Book Description
Publisher:
ISBN:
Category : Drugs
Languages : en
Pages : 24
Book Description
Guidelines for the Clinical Evaluation of General Anesthetics
Author:
Publisher:
ISBN:
Category : Anesthetics
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Anesthetics
Languages : en
Pages : 20
Book Description
Guidelines for the Clinical Evaluation of Radiopharmaceutical Drugs
Author: United States. Food and Drug Administration. Division of Oncology and Radiopharmaceutical Drug Products
Publisher:
ISBN:
Category : Radioisotopes
Languages : en
Pages : 24
Book Description
Publisher:
ISBN:
Category : Radioisotopes
Languages : en
Pages : 24
Book Description
Guidelines for the Clinical Evaluation of Antineoplastic Drugs
Author:
Publisher:
ISBN:
Category : Antineoplastic agents
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Antineoplastic agents
Languages : en
Pages : 20
Book Description
Coronary Primary Prevention Trial
Author:
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
Publisher:
ISBN:
Category : Coronary heart disease
Languages : en
Pages : 2
Book Description
General Considerations for the Clinical Evaluation of Drugs
Author: United States. Food and Drug Administration. Bureau of Drugs
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 20
Book Description
Publisher:
ISBN:
Category : Chemotherapy
Languages : en
Pages : 20
Book Description
Current Catalog
Author: National Library of Medicine (U.S.)
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1550
Book Description
First multi-year cumulation covers six years: 1965-70.
Publisher:
ISBN:
Category : Medicine
Languages : en
Pages : 1550
Book Description
First multi-year cumulation covers six years: 1965-70.
The Clinical Research Process in the Pharmaceutical Industry
Author: Gary M. Matoren
Publisher: CRC Press
ISBN: 1000148718
Category : Business & Economics
Languages : en
Pages : 584
Book Description
This book examines the sequence of events and methodology in the industrial clinical research process; a reference for multidisciplinary personnel. It is the conceptual framework involving the philosophical, economic, political, historical, regulatory, planning, and marketing aspects of the process.
Publisher: CRC Press
ISBN: 1000148718
Category : Business & Economics
Languages : en
Pages : 584
Book Description
This book examines the sequence of events and methodology in the industrial clinical research process; a reference for multidisciplinary personnel. It is the conceptual framework involving the philosophical, economic, political, historical, regulatory, planning, and marketing aspects of the process.
Lipid Management
Author: Hussein Yassine
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268
Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.
Publisher: Springer
ISBN: 3319111612
Category : Medical
Languages : en
Pages : 268
Book Description
This timely, concise title provides an important update on clinical lipid management. Using information from recent clinical trials and in special populations, the book begins by offering an easy-to-read overview of LDL, HDL, and triglyceride metabolism and the genetics of lipid disorders. The link between inflammation and lipids, and how this relates to atherosclerosis development, is also addressed, as are the measures of subclinical atherosclerosis in patients with abnormal lipid levels. Lipid abnormalities in children, with a particular focus on vulnerable populations (with an emphasis on ethnicity and childhood obesity), are covered. The treatment goals and approaches for managing lipids in the clinic are thoroughly discussed, emphasizing the important role of statin use and addressing controversies of lipid management in special populations such as heart failure, end stage kidney disease and fatty liver disease. Of special note, an important update on how new HIV medications impact lipid levels is provided. In all, Lipid Management: From Basics to Clinic, is an invaluable, handy resource for understanding changes in lipids in different populations and for sharpening the clinical approach to managing complicated lipid cases.